SAB Biotherapeutics SABS
NASDAQ SABS
$3.22 +0.01 (+0.16%)
At close: Sep 29, 2026 · 4:00 PM EDT

SAB Biotherapeutics (SABS) Operating Expenses (2020 - 2026)

Updated

SAB Biotherapeutics (SABS) reported Operating Expenses of $23.38 million for Q2 2026, up 140.2% from $9.73 million a year earlier and up 16.9% from the prior quarter.

Analysis

SAB Biotherapeutics (SABS) Operating Expenses (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, SAB Biotherapeutics' Operating Expenses came in at $71.82 million, up 71.3% year-over-year; for FY2025, it was $48.95 million, up 10.7% from FY2024.

  • Operating Expenses has a five-year compound annual growth rate of 7.1% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $44.23 million in FY2024 (+9.7%), $40.31 million in FY2023 (-23.7%), $52.82 million in FY2022 (-28.9%) and $74.27 million in FY2021 (+114.2%).
  • The Q2 2026 figure ranks as the highest quarterly Operating Expenses in data going back to Q4 2020.
  • Year over year, Operating Expenses has now increased in each of the last four quarters, with growth averaging 37.3% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q2 2026 (growth of 140.2%); the low point was Q1 2023 (a decline of 56.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $20 million (Q1 2026), $15.77 million (Q4 2025) and $12.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 SAB Biotherapeutics 268.01 Mn 268.01 Mn - 23.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.38 Mn
Mar 31, 2026 20.00 Mn
Dec 31, 2025 15.77 Mn
Sep 30, 2025 12.68 Mn
Jun 30, 2025 9.73 Mn
Mar 31, 2025 10.77 Mn
Dec 31, 2024 10.12 Mn
Sep 30, 2024 11.31 Mn
Jun 30, 2024 10.46 Mn
Mar 31, 2024 12.34 Mn
Dec 31, 2023 19.18 Mn
Sep 30, 2023 6.59 Mn
Jun 30, 2023 6.56 Mn
Mar 31, 2023 7.98 Mn
Dec 31, 2022 10.02 Mn
Sep 30, 2022 11.40 Mn
Jun 30, 2022 12.89 Mn
Mar 31, 2022 18.51 Mn
Dec 31, 2021 18.40 Mn
Sep 30, 2021 18.67 Mn
API Access

SAB Biotherapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=SABS&period=max&api_key=YOUR_API_KEY